# QuartzBio

> QuartzBio sells enterprise software to clinical-stage biotechnology and pharmaceutical companies that need to know where trial samples are, whether they were collected and tested correctly, and what their biomarker results mean. Its vendor-agnostic platform combines Sample Intelligence, Biomarker Intelligence and domain-specific AI agents, turning scattered lab files, clinical systems and spreadsheets into a continuously checked data layer for operations, translational science and R&D IT teams.

- **Founded:** 2012
- **Headquarters:** Frederick, United States
- **Founders:** Jérôme Wojcik (Founder and original CEO), Scott Marshall (CEO and Co-founder), Tobias Guennel (CTO and Co-founder)
- **Team size:** Approximately 63 employees in the supplied dataset; LinkedIn lists a 51-200 employee range.
- **Products:** Sample Intelligence, Biomarker Intelligence, Agent Intelligence, Enterprise Data Platform and implementation services
- **Notable:** QuartzBio says its platform is used by 25% of top pharmaceutical companies and 20% of top biotechnology companies., A 2026 company case study reports that a Top 5 pharmaceutical client doubled trial capacity by more than 100 studies without adding headcount., The same case study reports an 85% reduction in sample data-management effort and an estimated planning midpoint of about $239,000 saved per study.

## Products & services

- **Sample Intelligence** — Enterprise biospecimen management that creates a master sample inventory, monitors collections, consent, testing, shipments, stability, storage and protocol exceptions across vendors and studies.
- **Biomarker Intelligence** — A governed hub that ingests, maps, checks, searches, analyzes and visualizes clinical and multi-omics biomarker data from disparate files, labs and systems.
- **Agent Intelligence** — A network of domain-specific AI agents and a virtual assistant for natural-language questions, analytics, exception detection and semi-automated workflows across sample, clinical and biomarker data.
- **Enterprise Data Platform and implementation services** — Secure cloud infrastructure, APIs, data pipelines, configuration, validation, training and ongoing support for regulated biopharma deployments.

## Achievements

- QuartzBio says its platform is used by 25% of top pharmaceutical companies and 20% of top biotechnology companies.
- A 2026 company case study reports that a Top 5 pharmaceutical client doubled trial capacity by more than 100 studies without adding headcount.
- The same case study reports an 85% reduction in sample data-management effort and an estimated planning midpoint of about $239,000 saved per study.
- The platform is independently audited under SOC 2 Type II and supports GDPR, HIPAA, 21 CFR Part 11 and relevant GxP workflows.
- QuartzBio expanded its technology through the acquisitions of SimplicityBio in 2019 and SolveBio in 2023.
- Eir Partners acquired a controlling interest in QuartzBio in May 2026 through an undisclosed growth investment.

## Latest updates

- **2026-06** — Release 26R1 added easier sample-stability monitoring, faster folder and vault data management, richer mutation access and natural-language search for AI-enabled customers.
- **2026-05** — Eir Partners made a strategic growth investment and acquired a controlling interest; transaction terms were not disclosed.
- **2026-04** — QuartzBio published a Top 5 pharma case study reporting doubled trial capacity, faster insight and major reductions in manual sample reconciliation.
- **2025-12** — Platform version 13.0.0 introduced a Learning Lab, shareable homepages, Snowflake integration and new compliance dashboards.
- **2025-04** — QuartzBio demonstrated its Precision Medicine AI Agent Platform for conversational analysis and semi-autonomous data workflows.

## Links

- Website: https://quartz.bio/
- LinkedIn: https://www.linkedin.com/company/quartz-bio/
- Twitter/X: https://twitter.com/quartzbio
- Facebook: https://facebook.com/SolveBio

---

Profile page: https://yespress.io/quartzbio
Published by YesPress — https://yespress.io
Last updated: 2026-08-18